Tele: 561.316.3330

Breaking Medical Device Industry News

Thursday, October 28, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeArthrex IncArthrex Launches 1st and Only FDA-Cleared Kit for the Primary Repair of...

Arthrex Launches 1st and Only FDA-Cleared Kit for the Primary Repair of Anterior Cruciate Ligament Tears

December 18, 2020

Arthrex, a global leader in minimally invasive orthopedic technology, announced today the launch of the SwiveLock® ACL Repair Kit, following clearance by the U.S. Food and Drug Administration of the SwiveLock® anchor for ACL repair. It is the first and only FDA-cleared kit for the primary repair of anterior cruciate ligament (ACL) tears.

Arthrex is defining the future for ACL treatment as the first orthopedic company to develop and market a kit specifically for ACL repair,” said President and Founder Reinhold Schmieding. “This is a significant achievement in orthopedic surgery and another testament to Arthrex’s continuous innovation and dedication to its mission of Helping Surgeons Treat Their Patients Better™.”

ACL primary repair with the SwiveLock® ACL Repair Kit involves reattaching a torn ACL utilizing SwiveLock® anchors and high-strength FiberWire® and TigerWire® sutures. The repair utilizes an InternalBrace™ ligament augmentation, which enables patients to return to activity more quickly1 while protecting the repaired ligament. The kit is convenient and contains all the surgical products needed for the ACL repair technique.

Traditional treatment for most ACL tears involves a surgical reconstruction technique, in which graft tissue from the patient’s body or donor tissue is used to recreate the damaged ligament. What a patient receives – reconstruction or repair – is determined by numerous criteria, such as what portion of the ACL is torn, the quality of the remaining ACL tissue, the patient’s goals and activity level, and the acuteness from the initial injury. The kit is indicated for use in proximal ACL tears (tears off the femur), which results in roughly 16 percent of all ACL tears2.

“ACL primary repair offers a fully arthroscopic, more minimally invasive and patient-friendly surgical option for certain types of tears when compared to traditional reconstruction techniques,” said Arthrex Vice President of Strategic Development Larry Higgins, M.D. “Arthrex innovations in technology and techniques have significantly improved outcomes since the origination of this procedure 50 years ago and now provides surgeons the potential to restore a patient’s native anatomy and proprioception. These advancements may allow for a quicker return to activity and diminish pain following the procedure. While primary ‘repair’ will not replace reconstruction for all cases, the procedure, utilizing the SwiveLock® ACL Repair Kit, is a valuable tool to help surgeons treat their patients better.”

The first ACL primary repair with the new kit was completed on November 23, 2020 by Gregory DiFelice, M.D, an orthopedic surgeon at The Hospital for Special Surgery in New York who pioneered this technique and developed this kit in partnership with Arthrex.

“I am very excited about the release of the SwiveLock® ACL Repair Kit. I have been performing ACL primary repair using this technique for more than a decade now and we have developed this kit so that surgeons have all the tools necessary to make this procedure seamless,” he said.

Arthrex has been involved in developing the ACL primary repair procedure since 1983 with the goal of helping patients maintain their native tissue while returning to activity more quickly. In developing this technique and kit, the company has thoroughly studied the procedure and associated patient outcomes in peer reviewed literature3,4,5,6 as well as Arthrex’s Surgical Outcomes System™ (SOS), an orthopedic and sports medicine global registry that tracks patient outcomes following common orthopedic and sports medicine medical procedures across the U.S.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Join Our Email List & Receive a Recap of the Week's News!